JESSICA BRADBURN: Open Payments
NPI 1093130767 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 69 payments from 15 companies in 2025. Trend: 2023 $808 · 2024 $1,904 · 2025 $1,397
Food & beverage: $1,317Education: $80
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $242 |
| Teva Pharmaceuticals USA, Inc. | 10 | $238 |
| Neurocrine BioSciences, Inc. | 8 | $166 |
| ABBVIE INC. | 8 | $152 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Alkermes, Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Lundbeck LLC | 2 | $52 |
| Corium, LLC | 2 | $50 |
Products named: FANAPT, INGREZZA, VRAYLAR, SPRAVATO, UZEDY, CAPLYTA, Auvelity, REXULTI.
Industry payments across CO — which companies pay providers there.
